What is the Percheron Therapeutics (ASX: PER) share price?
The PER share price is $0.004, up 0.00% for the day, based on the latest available ASX market data.
What is Percheron Therapeutics's market capitalisation?
Percheron Therapeutics has a market capitalisation of $4.5M, making it the 1686th-largest security listed on the ASX.
Does Percheron Therapeutics pay a dividend?
PER does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Percheron Therapeutics profitable?
In its most recent reported period (ending 31 Dec 2025), PER reported revenue of $0 and a net loss of $3.1M.
How many PER shares are on issue?
Percheron Therapeutics has approximately 1,114,063,500 shares on issue, based on its market capitalisation of $4.5M and current share price.
What sector is Percheron Therapeutics in?
Percheron Therapeutics is classified in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry on the ASX.
When did Percheron Therapeutics list on the ASX?
Percheron Therapeutics listed on the Australian Securities Exchange on 26 Dec 2023.
